Kedrion Explores $2 Billion Debt Raise to Fund Dividend
Italian biopharmaceutical company Kedrion is exploring a debt package of roughly $2 billion, with the proceeds potentially being used to ...
Italian biopharmaceutical company Kedrion is exploring a debt package of roughly $2 billion, with the proceeds potentially being used to ...
Canadian Telecom Prioritizes Balance Sheet Strength as Heavy Investment and Borrowing Pressures Cash Flow TELUS Corp. has announced a dramatic ...
I don’t want startup news.
I don’t want startup news.